anemia.
Conditions
Interventions
Intervention 1: intervention group: 50 patients in this group receiving 50000 unit per week (pearl, Manufacturing Co. Zahravi) for 8 weeks. Intervention 2: Control group: 50 patients in placebo group
Treatment - Drugs
intervention group: 50 patients in this group receiving 50000 unit per week (pearl, Manufacturing Co. Zahravi) for 8 weeks.
Control group: 50 patients in placebo group receiving placebo (pearl, Manufacturing Co. Zahravi) for 8 weeks.
Sponsors
Vice Chancellor for research of Zahedan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: inclusion criteria :all diabetic cases with anemia based on WHO criteria and mild renal impairment according to Staging ( KDIGO 2012 exclusion criteria:history of transfusion during 3 months ago/history of recent bleeding/history of recent infection during 2 months ago/history of supplement therapy/pregnancy/smoking/chronic disease of liver/kidney hypercalcemia/hyperparathyroidesim/explained anemia
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hemoglobin and vitamin D before intervention and 8 weeks after interventin. Timepoint: before intervention and at the end of intervention ( end of second month). Method of measurement: enzyme immunoassay method (EIA) [immunodiagnostic system; IDS (LTD), UK]. | — |
Secondary
| Measure | Time frame |
|---|---|
| Srum 25 hydroxy vitamin D. Timepoint: 8 WEEKS. Method of measurement: enzyme immunoassay method (EIA). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public Contactseyed mehdi hashemi
seyed mehdi hashemi
Outcome results
None listed